Peptide science,
engineered for market
Epithaneer partners with biotech, pharma, and cosmeceutical teams across the USA and UK to take peptides from sequence to supply chain. We de-risk chemistry, scale manufacturing, and clear the regulatory path — so your program reaches the market faster.
Businesses served
Focused markets
Manufacturing network
What we do
End-to-end peptide expertise, on demand
One partner across the full lifecycle — so you don't have to stitch together a dozen specialists to move a molecule forward.
Sequence & Molecular Design
Rational design, modification, and optimization of peptide sequences — cyclization, stapling, PEGylation, and non-natural amino acids to tune potency, stability, and half-life.
Synthesis & Process Chemistry
SPPS and hybrid route selection, impurity profiling, and yield optimization. We translate bench chemistry into robust, cost-aware manufacturing processes.
CDMO Sourcing & Scale-Up
We vet, select, and manage GMP manufacturing partners across our global network — matching your program to the right capacity, quality system, and price point.
Regulatory & Quality Strategy
CMC dossiers, impurity qualification, and regulatory roadmaps for FDA, EMA, and beyond. We anticipate reviewer questions before they land.
Market & Commercial Diligence
Landscape analysis, IP whitespace, cost-of-goods modeling, and go-to-market strategy for therapeutic, cosmetic, and research-grade peptides.
R&D Advisory & Training
Fractional peptide expertise for your team — from troubleshooting a stubborn synthesis to standing up an internal peptide platform and upskilling chemists.
How we work
A clear path from idea to inventory
No jargon-for-hire, no open-ended retainers. Every engagement is scoped to deliverables and decision points you control.
Talk through your program01Discover
We map your molecule, targets, and constraints — technical, regulatory, and commercial — and pressure-test the program's assumptions.
02Design
A concrete plan: sequence strategy, synthesis route, sourcing shortlist, and a regulatory path with clear decision gates.
03Deliver
We execute alongside your team — running tech transfer, managing CDMOs, and qualifying material to spec.
04De-risk
Ongoing oversight: impurity control, second-source strategy, and audit-ready documentation that keeps your supply resilient.
Businesses served
Avg. COGS reduction achieved
Core markets — USA & UK
Faster to qualified material
Why Epithaneer
The specialist edge, without the specialist overhead
Peptides punish generalist assumptions. A wrong protecting group, an unqualified impurity, or the wrong CDMO can cost quarters. We bring the depth to get it right the first time.
Chemists, not middlemen
Advice comes from people who have run the syntheses and signed off the batches — not a rolodex with a markup.
Vendor-neutral network
We hold no manufacturing stake, so our CDMO recommendations serve your economics and timeline — nothing else.
Full-lifecycle fluency
From a single residue swap to a global GMP supply chain, one team keeps the science and the strategy aligned.
Let's talk
Move your peptide program forward
Tell us where you are — discovery, scale-up, or stuck. We reply within one business day with a clear next step, no pitch-deck runaround.